Application of endobronchial ultrasound-guided transbronchial needle aspiration following integrated PET/CT in mediastinal staging of potentially operable non-small cell lung cancer.

PubWeight™: 1.11‹?› | Rank: Top 10%

🔗 View Article (PMID 19118267)

Published in Chest on December 31, 2008

Authors

Bin Hwangbo1, Seok Ki Kim, Hee-Seok Lee, Hyun Sung Lee, Moon Soo Kim, Jong Mog Lee, Hyae-Young Kim, Geon-Kook Lee, Byung-Ho Nam, Jae Ill Zo

Author Affiliations

1: Center for Lung Cancer, Research Institute for National Cancer Control & Evaluation, National Cancer Center, Goyang, Gyeonggi, Korea.

Articles citing this

Advances in diagnostic bronchoscopy. Am J Respir Crit Care Med (2010) 1.18

18F-FDG PET/CT in mediastinal lymph node staging of non-small-cell lung cancer in a tuberculosis-endemic country: consideration of lymph node calcification and distribution pattern to improve specificity. Eur J Nucl Med Mol Imaging (2009) 1.06

Ultrasound techniques in the evaluation of the mediastinum, part I: endoscopic ultrasound (EUS), endobronchial ultrasound (EBUS) and transcutaneous mediastinal ultrasound (TMUS), introduction into ultrasound techniques. J Thorac Dis (2015) 0.87

Endoscopic ultrasound in the diagnosis and staging of lung cancer. Endosc Ultrasound (2014) 0.87

A combination of smears and cell block preparations provides high diagnostic accuracy for endobronchial ultrasound-guided transbronchial needle aspiration. Virchows Arch (2012) 0.85

Linear probe endobronchial ultrasound bronchoscopy with guided transbronchial needle aspiration (EBUS-TBNA) in the evaluation of mediastinal and hilar pathology: introducing the procedure to a teaching institution. Lung (2012) 0.84

Interventional pulmonology approaches in the diagnosis and treatment of early stage non small cell lung cancer. Transl Lung Cancer Res (2013) 0.84

Comparison of Endobronchial Ultrasound-Guided Fine Needle Aspiration and Video-Assisted Mediastinoscopy for Mediastinal Staging of Lung Cancer. Lung (2015) 0.84

Current concepts in F18 FDG PET/CT-based radiation therapy planning for lung cancer. Front Oncol (2012) 0.83

The role of convex probe endobronchial ultrasound guided transbronchial needle aspiration in the diagnosis of malignant mediastinal and hilar lymph nodes. Iran J Radiol (2012) 0.82

Differences in clinical presentation of non-small cell lung cancer in never-smokers versus smokers. J Thorac Dis (2013) 0.80

A new tool for distinguishing muscle invasive and non-muscle invasive bladder cancer: the initial application of flexible ultrasound bronchoscope in bladder tumor staging. PLoS One (2014) 0.78

The clinical significance of subcarinal lymph node dissection in the radical resection of oesophageal cancer. Interact Cardiovasc Thorac Surg (2013) 0.78

Endobronchial ultrasound-guided transbronchial needle aspiration in diagnosing mediastinal lymphadenopathy. Lung India (2017) 0.77

Use of Positron Emission Tomography/Computed Tomography in Radiation Treatment Planning for Lung Cancer. Mol Imaging Radionucl Ther (2016) 0.76

Texture Analysis and Synthesis of Malignant and Benign Mediastinal Lymph Nodes in Patients with Lung Cancer on Computed Tomography. Sci Rep (2017) 0.75

Endobronchial ultrasound: morphological predictors of benign disease. ERJ Open Res (2016) 0.75

Endobronchial ultrasound for lung cancer diagnosis and staging: a review of the clinical and cost-effectiveness. CADTH Technol Overv (2010) 0.75

Direct nodal sampling by echoendoscopy in lung cancer: the clinician's expectations: Direct nodal sampling by echoendoscopy in lung cancer. Insights Imaging (2011) 0.75

Staging lung cancer: role of endobronchial ultrasound. Lung Cancer (Auckl) (2014) 0.75

Understanding local performance data for EBUS-TBNA: insights from an unselected case series at a high volume UK center. J Thorac Dis (2017) 0.75

The diagnostic ability of (18)F-FDG PET/CT for mediastinal lymph node staging using (18)F-FDG uptake and volumetric CT histogram analysis in non-small cell lung cancer. Eur Radiol (2016) 0.75

Articles by these authors

Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA (2004) 4.63

C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study. Arch Intern Med (2005) 3.31

Randomized clinical trial of weekly vs. triweekly cisplatin-based chemotherapy concurrent with radiotherapy in the treatment of locally advanced cervical cancer. Int J Radiat Oncol Biol Phys (2011) 3.01

Association of family history with cancer recurrence and survival in patients with gastric cancer. J Clin Oncol (2012) 2.97

Phase II study of concurrent transarterial chemoembolization and sorafenib in patients with unresectable hepatocellular carcinoma. J Hepatol (2012) 2.94

Accuracy of offspring reports of parental cardiovascular disease history: the Framingham Offspring Study. Ann Intern Med (2004) 2.74

Free jejunal graft for esophageal reconstruction using end-to-side vascular anastomosis and extended pharyngo-jejunostomy. Ann Thorac Surg (2012) 2.66

Resumption of imatinib to control metastatic or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib (RIGHT): a randomised, placebo-controlled, phase 3 trial. Lancet Oncol (2013) 2.42

A likely explanation for the J-curve of blood pressure cardiovascular risk. Am J Cardiol (2004) 2.36

Real-time endobronchial ultrasound-guided transbronchial needle aspiration in mediastinal staging of non-small cell lung cancer: how many aspirations per target lymph node station? Chest (2008) 2.31

Transbronchial and transesophageal fine-needle aspiration using an ultrasound bronchoscope in mediastinal staging of potentially operable lung cancer. Chest (2010) 2.28

EBUS-centred versus EUS-centred mediastinal staging in lung cancer: a randomised controlled trial. Thorax (2013) 2.21

Surgical complications and the risk factors of laparoscopy-assisted distal gastrectomy in early gastric cancer. Ann Surg Oncol (2008) 2.10

Sibling cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults. JAMA (2005) 2.05

Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study. Arterioscler Thromb Vasc Biol (2002) 2.00

Abdominal visceral adipose tissue volume is associated with increased risk of erosive esophagitis in men and women. Gastroenterology (2010) 2.00

Phase III, multicenter, randomized trial of maintenance chemotherapy versus observation in patients with metastatic breast cancer after achieving disease control with six cycles of gemcitabine plus paclitaxel as first-line chemotherapy: KCSG-BR07-02. J Clin Oncol (2013) 1.96

Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations. Nat Genet (2010) 1.90

Prognostic value of preoperative clinical staging assessed by computed tomography in resectable gastric cancer patients: a viewpoint in the era of preoperative treatment. Ann Surg (2010) 1.84

Relations of insulin sensitivity to longitudinal blood pressure tracking: variations with baseline age, body mass index, and blood pressure. Circulation (2005) 1.75

Association of parental heart failure with risk of heart failure in offspring. N Engl J Med (2006) 1.69

Tumor necrosis as a prognostic factor for stage IA non-small cell lung cancer. Ann Thorac Surg (2011) 1.69

C-reactive protein, inflammatory conditions, and cardiovascular disease risk. Am J Med (2007) 1.64

Intrathoracic gastric emptying of solid food after esophagectomy for esophageal cancer. Ann Thorac Surg (2005) 1.62

Patterns of lymph node metastasis and survival for upper esophageal squamous cell carcinoma. Ann Thorac Surg (2011) 1.59

Dose-volumetric parameters for predicting severe radiation pneumonitis after three-dimensional conformal radiation therapy for lung cancer. Radiology (2005) 1.57

Low initial human papilloma viral load implicates worse prognosis in patients with uterine cervical cancer treated with radiotherapy. J Clin Oncol (2009) 1.56

Survival of patients with advanced hepatocellular carcinoma: sorafenib versus other treatments. J Gastroenterol Hepatol (2011) 1.55

A prospective evaluation of 18F-FDG and 11C-acetate PET/CT for detection of primary and metastatic hepatocellular carcinoma. J Nucl Med (2008) 1.54

Wedge bronchoplastic lobectomy for non-small cell lung cancer as an alternative to sleeve lobectomy. J Thorac Cardiovasc Surg (2011) 1.53

Developing an institutional protocol guideline for laparoscopy-assisted distal gastrectomy. Ann Surg Oncol (2009) 1.51

Early intrapulmonary recurrence after pulmonary metastasectomy related to colorectal cancer. Ann Thorac Surg (2010) 1.49

Association between increment of serum VEGF level and prognosis after transcatheter arterial chemoembolization in hepatocellular carcinoma patients. Cancer Sci (2008) 1.44

Reference intervals for circulating angiogenic cytokines. Clin Chem Lab Med (2008) 1.40

Reversal of drug resistance in breast cancer cells by transglutaminase 2 inhibition and nuclear factor-kappaB inactivation. Cancer Res (2006) 1.36

Web-based tailored education program for disease-free cancer survivors with cancer-related fatigue: a randomized controlled trial. J Clin Oncol (2012) 1.34

Worse prognosis of metaplastic breast cancer patients than other patients with triple-negative breast cancer. Breast Cancer Res Treat (2010) 1.30

Comparison of the early robot-assisted lobectomy experience to video-assisted thoracic surgery lobectomy for lung cancer: a single-institution case series matching study. Innovations (Phila) (2011) 1.30

Validity of an adaptation of the Framingham cardiovascular risk function: the VERIFICA Study. J Epidemiol Community Health (2007) 1.28

Dietary patterns and the metabolic syndrome in obese and non-obese Framingham women. Obes Res (2005) 1.23

Endogenous sex hormones and cardiovascular disease incidence in men. Ann Intern Med (2006) 1.22

Site-specific risk factors for colorectal cancer in a Korean population. PLoS One (2011) 1.21

Multimodality assessment of esophageal cancer: preoperative staging and monitoring of response to therapy. Radiographics (2009) 1.21

Electrocardiographic QRS duration and the risk of congestive heart failure: the Framingham Heart Study. Hypertension (2006) 1.18

Germ line mutations of mismatch repair genes in hereditary nonpolyposis colorectal cancer patients with small bowel cancer: International Society for Gastrointestinal Hereditary Tumours Collaborative Study. Clin Cancer Res (2006) 1.18

Is the sentinel node biopsy clinically applicable for limited lymphadenectomy and modified gastric resection in gastric cancer? A meta-analysis of feasibility studies. J Surg Oncol (2011) 1.18

Learning curves for laparoscopic sigmoidectomy used to manage curable sigmoid colon cancer: single-institute, three-surgeon experience. Surg Endosc (2008) 1.18

A genome-wide association study reveals susceptibility variants for non-small cell lung cancer in the Korean population. Hum Mol Genet (2010) 1.17

Aetiology of cancer in Asia. Asian Pac J Cancer Prev (2008) 1.15

Single nucleotide polymorphisms of CYP19A1 predict clinical outcomes and adverse events associated with letrozole in patients with metastatic breast cancer. Cancer Chemother Pharmacol (2011) 1.13

Sentinel node mapping and skip metastases in patients with early gastric cancer. Ann Surg Oncol (2009) 1.11

Stroke risk prediction model: a risk profile from the Korean study. Atherosclerosis (2007) 1.10

Learning curve for total gastrectomy with D2 lymph node dissection: cumulative sum analysis for qualified surgery. Ann Surg Oncol (2006) 1.10

Risk stratification of obesity as a coronary risk factor. Am J Cardiol (2002) 1.09

Extent of routine central lymph node dissection with small papillary thyroid carcinoma. World J Surg (2007) 1.08

Validation of the MSKCC and Heng risk criteria models for predicting survival in patients with metastatic renal cell carcinoma treated with sunitinib. Ann Surg Oncol (2013) 1.08

Effect of Helicobacter pylori infection and its eradication on reflux esophagitis and reflux symptoms. Am J Gastroenterol (2010) 1.08

Association of the interval between endoscopies with gastric cancer stage at diagnosis in a region of high prevalence. Cancer (2012) 1.07

Feasibility of laparoscopic sentinel basin dissection for limited resection in early gastric cancer. J Surg Oncol (2008) 1.06

Repair of gastrotracheal fistula with a pedicled pericardial flap after Ivor Lewis esophagogastrectomy for esophageal cancer. J Thorac Cardiovasc Surg (2006) 1.05

Balloon dilatation of the pylorus for delayed gastric emptying after esophagectomy. Eur J Cardiothorac Surg (2008) 1.05

Gastric cancer and salt preference: a population-based cohort study in Korea. Am J Clin Nutr (2010) 1.05

Preoperative serum CA-125 levels and risk of suboptimal cytoreduction in ovarian cancer: a meta-analysis. J Surg Oncol (2010) 1.04

Does neoadjuvant chemotherapy increase optimal cytoreduction rate in advanced ovarian cancer? Meta-analysis of 21 studies. Ann Surg Oncol (2009) 1.04

A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer. Breast Cancer Res Treat (2007) 1.04

Predicting tissue HER2 status using serum HER2 levels in patients with metastatic breast cancer. Clin Chem (2006) 1.04

Lipid MALDI profile classifies non-small cell lung cancers according to the histologic type. Lung Cancer (2011) 1.03

Successful treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis with HLH-94 protocol. J Korean Med Sci (2005) 1.03

Carotid intima-media thickness is associated with premature parental coronary heart disease: the Framingham Heart Study. Circulation (2003) 1.02

Clinical characteristics of malignant pericardial effusion associated with recurrence and survival. Cancer Res Treat (2010) 1.02